Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The MAPK pathway as an apoptosis enhancer in melanoma

8 Jun 2014

Abstract excerpt

// Johannes M. Haydn 1 , Anita Hufnagel 1 , Johannes Grimm 1 , Katja Maurus 1 , Manfred Schartl 1,2 and Svenja Meierjohann 1,2 1 Department of Physiological Chemistry, Biocenter, University of Wurzburg, Wurzburg, Germany 2 Comprehensive Cancer Center Mainfranken, University Hospital Wurzburg, Germany Correspondence: Svenja Meierjohann, email: // Keywords : Crosstalk, chemotherapy resistance, RAS, PI3K, melanoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cytokine Signaling Pathways and Interactions
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24970815
DOI: 10.18632/oncotarget.2079

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The MAPK pathway as an apoptosis enhancer in melanomaPMID 24970815Read ↗

Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer TherapySemantic proximity Read ↗

The MEK/ERK Network as a Therapeutic Target in Human CancerSemantic proximity Read ↗

Specifically targeting ERK1 or ERK2 kills Melanoma cellsSemantic proximity Read ↗

Novel mechanisms and therapeutic approaches in melanoma: targeting the MAPK pathway.Semantic proximity Read ↗

Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.Semantic proximity Read ↗

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma.Semantic proximity Read ↗

Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma.Semantic proximity Read ↗

[Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma].Semantic proximity Read ↗

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma.Semantic proximity Read ↗

Non-Apoptotic Cell Death Signaling Pathways in MelanomaSemantic proximity Read ↗

PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In VivoSemantic proximity Read ↗

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.